RFPL4AL1

gene
On this page

Also known as RNF210B

Summary

RFPL4AL1 (ret finger protein like 4A like 1, HGNC:45147) is a protein-coding gene on chromosome 19q13.42, encoding Ret finger protein-like 4A-like protein 1 (F8VTS6).

Predicted to enable ubiquitin protein ligase activity. Predicted to be involved in innate immune response and regulation of gene expression. Predicted to be active in cytoplasm.

Source: NCBI Gene 729974 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 1 total
  • MANE Select transcript: NM_001277397

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:45147
Approved symbolRFPL4AL1
Nameret finger protein like 4A like 1
Location19q13.42
Locus typegene with protein product
StatusApproved
AliasesRNF210B
Ensembl geneENSG00000229292
Ensembl biotypeprotein_coding
Entrez729974

Gene structure

Transcript identifiers

Ensembl transcripts: 1 — 1 protein_coding

ENST00000341750

RefSeq mRNA: 1 — MANE Select: NM_001277397 NM_001277397

CCDS: CCDS59425

Canonical transcript exons

ENST00000341750 — 3 exons

ExonStartEnd
ENSE000017119585576911855769175
ENSE000024780595577260255773420
ENSE000025344505577179655772090

Expression profiles

Bgee: expression breadth broad, 32 present calls, max score 87.45.

Top tissues by expression

117 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047387.45gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099184.73gold quality
right lobe of liverUBERON:000111456.17gold quality
granulocyteCL:000009454.70gold quality
liverUBERON:000210749.80gold quality
vermiform appendixUBERON:000115444.21gold quality
colonic epitheliumUBERON:000039742.32gold quality
duodenumUBERON:000211439.19gold quality
bone marrow cellCL:000209238.60gold quality
leukocyteCL:000073837.79gold quality
monocyteCL:000057637.49gold quality
ventricular zoneUBERON:000305336.48gold quality
cortical plateUBERON:000534336.47gold quality
ganglionic eminenceUBERON:000402335.49gold quality
skeletal muscle tissueUBERON:000113434.93gold quality
bone marrowUBERON:000237134.22gold quality
testisUBERON:000047333.78gold quality
lymph nodeUBERON:000002933.69gold quality
bloodUBERON:000017832.99gold quality
left testisUBERON:000453332.54gold quality
hindlimb stylopod muscleUBERON:000425232.15gold quality
right testisUBERON:000453431.77gold quality
sural nerveUBERON:001548830.93gold quality
islet of LangerhansUBERON:000000630.68gold quality
urinary bladderUBERON:000125530.36gold quality
pancreasUBERON:000126429.90gold quality
stromal cell of endometriumCL:000225529.87gold quality
gall bladderUBERON:000211029.85gold quality
small intestineUBERON:000210829.84silver quality
kidneyUBERON:000211329.52gold quality

Single-cell (SCXA)

Detected in 3 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-MTAB-3929yes413.02
E-MTAB-6142no31.74
E-ANND-3no1.30

Regulation

Is transcription factor: no

Cross-species orthologs

1 orthologs

OrganismSymbolGene ID
mus_musculusRfpl4ENSMUSG00000035191

Paralogs (12): CD86 (ENSG00000114013), CD274 (ENSG00000120217), CD80 (ENSG00000121594), RFPL1 (ENSG00000128250), RFPL2 (ENSG00000128253), RFPL3 (ENSG00000128276), SPRYD4 (ENSG00000176422), RNF152 (ENSG00000176641), RNF135 (ENSG00000181481), PDCD1LG2 (ENSG00000197646), RFPL4A (ENSG00000223638), RFPL4B (ENSG00000251258)

Protein

Protein identifiers

Ret finger protein-like 4A-like protein 1F8VTS6 (reviewed: F8VTS6)

All UniProt accessions (1): F8VTS6

RefSeq proteins (1): NP_001264326* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR001841Znf_RINGDomain
IPR001870B30.2/SPRYDomain
IPR003877SPRY_domDomain
IPR003879Butyrophylin_SPRYDomain
IPR006574PRYDomain
IPR013083Znf_RING/FYVE/PHDHomologous_superfamily
IPR013320ConA-like_dom_sfHomologous_superfamily
IPR022723RDM_domain_RFPLDomain
IPR037960SPRY/PRY_RFPLDomain
IPR043136B30.2/SPRY_sfHomologous_superfamily
IPR050143TRIM/RBCCFamily

Pfam: PF00622, PF11002, PF13765, PF15227

UniProt features (5 total): sequence conflict 2, chain 1, domain 1, zinc finger region 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-F8VTS6-F191.160.77

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 7 (showing top): GOBP_DEFENSE_RESPONSE_TO_OTHER_ORGANISM, GOMF_ACYLTRANSFERASE_ACTIVITY, GOMF_AMINOACYLTRANSFERASE_ACTIVITY, GOMF_UBIQUITIN_LIKE_PROTEIN_LIGASE_ACTIVITY, GOBP_BIOLOGICAL_PROCESS_INVOLVED_IN_INTERSPECIES_INTERACTION_BETWEEN_ORGANISMS, HE_LIM_SUN_FETAL_LUNG_C2_DC1_CELL, chr19q13

GO Biological Process (2): regulation of gene expression (GO:0010468), innate immune response (GO:0045087)

GO Molecular Function (4): zinc ion binding (GO:0008270), ubiquitin protein ligase activity (GO:0061630), protein binding (GO:0005515), metal ion binding (GO:0046872)

GO Cellular Component (1): cytoplasm (GO:0005737)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
gene expression1
regulation of macromolecule biosynthetic process1
immune response1
defense response to symbiont1
transition metal ion binding1
ubiquitin-protein transferase activity1
ubiquitin-like protein ligase activity1
binding1
cation binding1
intracellular anatomical structure1
cellular anatomical structure1

Protein interactions and networks

STRING

158 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
RFPL4AL1RASD1Q9Y272186
RFPL4AL1HOXB13Q92826167
RFPL4AL1RASD2Q96D21159
RFPL4AL1MOSP00540136
RFPL4AL1H1-8Q8IZA3112
RFPL4AL1OAS3Q9Y6K574
RFPL4AL1RPSAP0886572
RFPL4AL1CXorf66Q5JRM272
RFPL4AL1SMKR1H3BMG370
RFPL4AL1PPP1R26Q5T8A770
RFPL4AL1MRPS2Q9Y39970
RFPL4AL1NLRP4Q96MN267
RFPL4AL1PRAMEF12O9552253
RFPL4AL1PRAMEF8Q5VWM453
RFPL4AL1PRAMEF7Q5VXH553

IntAct

0 interactions, top by confidence:

BioGRID (8): RFPL4AL1 (Proximity Label-MS), RFPL4AL1 (Proximity Label-MS), RFPL4AL1 (Proximity Label-MS), RFPL4AL1 (Proximity Label-MS), RFPL4AL1 (Proximity Label-MS), RFPL4AL1 (Proximity Label-MS), RFPL4AL1 (Proximity Label-MS), RFPL4AL1 (Proximity Label-MS)

ESM2 similar proteins: A6NK02, A6NLU0, D4ABM4, F8VTS6, O00635, O19085, O77666, P14373, P15533, P62603, P86448, P86449, Q12899, Q2T9Z0, Q3UWZ0, Q495X7, Q58DK8, Q5BK82, Q5D7H7, Q5D7I6, Q5E9G4, Q5RBG2, Q5SZ99, Q5TM55, Q62158, Q62191, Q640S6, Q6AZZ1, Q6PGR9, Q7TPM3, Q7YR32, Q7YR33, Q7YR34, Q7YRV4, Q80X56, Q86WT6, Q8BVP1, Q8K243, Q8N7C3, Q8N9V2

Diamond homologs: A0A0E4BZH1, A0JN74, A4QPC6, A6NGJ6, A6NI03, A6NK02, A6NLU0, A7TZE6, A7TZF0, A7TZF3, A7XUX6, A7XUY5, A7XUZ6, A7XV04, A7XV07, A8MVZ5, B1H278, D4ABM4, F8S122, F8VTS6, O00478, O00481, O00635, O15553, O70355, O75677, O75678, O75679, P14373, P18892, P19474, P55803, P78410, Q02084, Q13410, Q1XHU0, Q27J48, Q2T9Z0, Q3UWZ0, Q495X7

SIGNOR signaling

1 interactions.

AEffectBMechanism
Ub:E2“up-regulates activity”RFPL4AL1ubiquitination

Disease & clinical

Clinical variants and AI predictions

ClinVar

1 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance0
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

195 predictions. Top by Δscore:

VariantEffectΔscore
19:55771792:A:AGacceptor_gain1.0000
19:55771792:ACAG:Aacceptor_loss1.0000
19:55771793:C:Gacceptor_gain1.0000
19:55771793:CAGAC:Cacceptor_loss1.0000
19:55771794:A:AGacceptor_gain1.0000
19:55771794:AGACA:Aacceptor_loss1.0000
19:55771795:G:GAacceptor_gain1.0000
19:55771795:GA:Gacceptor_gain1.0000
19:55771795:GAC:Gacceptor_gain1.0000
19:55771795:GACA:Gacceptor_gain1.0000
19:55771795:GACAT:Gacceptor_gain1.0000
19:55772080:G:GTdonor_gain1.0000
19:55772086:TCAAG:Tdonor_loss1.0000
19:55772087:CAAGG:Cdonor_loss1.0000
19:55772088:AAGG:Adonor_loss1.0000
19:55772089:AGGT:Adonor_loss1.0000
19:55772090:GGTAA:Gdonor_loss1.0000
19:55772091:G:GAdonor_loss1.0000
19:55772091:G:GGdonor_gain1.0000
19:55772092:T:Adonor_loss1.0000
19:55772598:A:AGacceptor_gain1.0000
19:55772598:ACAGT:Aacceptor_gain1.0000
19:55772599:C:Gacceptor_gain1.0000
19:55772600:A:AGacceptor_gain1.0000
19:55772600:AGT:Aacceptor_gain1.0000
19:55772600:AGTG:Aacceptor_gain1.0000
19:55772601:G:GGacceptor_gain1.0000
19:55772601:GT:Gacceptor_gain1.0000
19:55772601:GTG:Gacceptor_gain1.0000
19:55772601:GTGG:Gacceptor_gain1.0000

AlphaMissense

1907 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
19:55772715:T:CF134L0.987
19:55772717:C:AF134L0.987
19:55772717:C:GF134L0.987
19:55772871:T:CF186L0.981
19:55772873:C:AF186L0.981
19:55772873:C:GF186L0.981
19:55772084:T:CF94L0.979
19:55772086:T:AF94L0.979
19:55772086:T:GF94L0.979
19:55772772:T:AW153R0.979
19:55772772:T:CW153R0.979
19:55772774:G:CW153C0.976
19:55772774:G:TW153C0.976
19:55773000:T:CF229L0.976
19:55773002:T:AF229L0.976
19:55773002:T:GF229L0.976
19:55772802:T:AW163R0.975
19:55772802:T:CW163R0.975
19:55772819:C:GC168W0.969
19:55772872:T:CF186S0.966
19:55772818:G:AC168Y0.961
19:55772734:T:AV140D0.957
19:55772812:G:AG166D0.956
19:55772811:G:CG166R0.953
19:55772804:G:CW163C0.949
19:55772804:G:TW163C0.949
19:55773072:T:CF253L0.949
19:55773074:T:AF253L0.949
19:55773074:T:GF253L0.949
19:55772817:T:CC168R0.948

dbSNP variants (sampled 300 via entrez): RS1001568531 (19:55767281 T>C), RS1003141898 (19:55769401 A>C), RS1004909345 (19:55772674 G>A,T), RS1007697800 (19:55769317 C>G,T), RS1009410346 (19:55770559 A>G), RS1011458927 (19:55767806 G>A), RS1011824686 (19:55767436 G>A), RS1013591366 (19:55770252 A>G), RS1015934228 (19:55767967 G>A), RS1017582967 (19:55770611 G>A,T), RS1018031417 (19:55770353 A>G), RS1020048044 (19:55767843 T>C,G), RS1021718888 (19:55770259 C>A,T), RS1023476248 (19:55772939 G>A,T), RS1025895178 (19:55768709 T>C)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

8 total (human), top 8 by PubMed support.

ChemicalActions (top 5)PubMed papers
2-methyl-4-isothiazolin-3-oneincreases expression1
sodium arseniteincreases expression1
zinc chromateincreases abundance, increases expression1
gallium arsenideincreases expression1
chromium hexavalent ionincreases abundance, increases expression1
abrineincreases expression1
(+)-JQ1 compoundincreases expression1
Okadaic Acidincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.